Antimicrobial Pharmacodynamics
Antimicrobial pharmacodynamics is the study of the relationship between the concentration of an antimicrobial agent over time at the site of infection and its resulting microbiological effect. This research field investigates how drug exposure parameters correlate with bacterial killing or inhibition, providing a scientific basis for optimizing dosing regimens to enhance clinical outcomes and mitigate the development of resistance.
10.3K
Publications
442.8K
Citations
36.6K
Authors
5.8K
Institutions
Publications per year
2017–2026
1.6K
10.3K
Research papers and scholarly works on Antimicrobial Pharmacodynamics.
| Year | Citations | |
|---|---|---|
2011 | 4.1K | |
1980 | 2.8K | |
1986 | 2.2K | |
2011 | 1.6K | |
2013 | 1.1K |
Rows per page
1–5 of 10.3K
36.6K
Leading researchers in Antimicrobial Pharmacodynamics. Counts cover only their work on this concept, not their overall record.
| Publications | Citations | H-Index | |
|---|---|---|---|
DP Hartford Hospital | 79 | 3.4K | 37 |
MJ Wayne State University | 62 | 9.4K | 37 |
RN JMI Laboratories | 66 | 3.5K | 37 |
GL Albany Medical Center Hospital | 49 | 4.5K | 33 |
DR University of Wisconsin–Madison | 34 | 3K | 28 |
Rows per page
1–5 of 36.6K
5.8K
Leading universities and research organizations in Antimicrobial Pharmacodynamics. Counts cover only their work on this concept, not their overall record.
| Publications | Citations | H-Index | |
|---|---|---|---|
Detroit, United States | 244 | 26.7K | 45 |
Madison, United States | 183 | 12.9K | 42 |
Hartford, United States | 232 | 10.1K | 38 |
North Liberty, United States | 212 | 10.7K | 37 |
Cambridge, United States | 236 | 22.6K | 36 |
Rows per page
1–5 of 5.8K
Leading journals and conferences in Antimicrobial Pharmacodynamics. Counts cover only their publications on this concept, not their overall record.
| Publications | Citations | H-Index | |
|---|---|---|---|
1.3K | 74.7K | 126 | |
906 | 29.7K | 71 | |
405 | 16.2K | 59 | |
136 | 9.8K | 58 | |
86 | 15.2K | 52 |
Rows per page
1–5